ORGO Short Volume
Organogenesis Holdings Inc. (ORGO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $347.4M, listed on NASDAQ, employing roughly 869 people, carrying a beta of 1.31 to the broader market. Organogenesis Holdings Inc. Led by Gary S. Gillheeney, public since 2017-01-05.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 414.9K
- Total Volume
- 563.2K
- Short %
- 73.66%
- 30-Day Avg Short %
- 59.26%
Showing 30 days of FINRA short volume data for Organogenesis Holdings Inc..
Learn how short volume is reported and how to read the data →
Frequently asked ORGO short volume questions
- What is the daily ORGO short volume?
- As of May 15, 2026, Organogenesis Holdings Inc. (ORGO) short volume is 414.9K shares against 563.2K total reported volume, or 73.66% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is ORGO short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does ORGO short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.